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§Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PennsylvaniaABSTRACT Virus capsid assembly has attracted considerable interest from the biophysical modeling community as a model
system for complicated self-assembly processes. Simulation methods have proven valuable for characterizing the space of
possible kinetics and mechanisms of capsid assembly, but they have so far been able to say little about the assembly kinetics
or pathways of any specific virus. It is not possible to directly measure the detailed interaction rates needed to parameterize
a model, and there is only a limited amount of experimental evidence available to constrain possible pathways, with almost
all of it gathered from in vitro studies of purified coat proteins. In prior work, we developed methods to address this problem
by using simulation-based data-fitting to learn rate parameters consistent with both structure-based rule sets and experimental
light-scattering data on bulk assembly progress in vitro. We have since improved these methods and extended them to fit
simulation parameters to one or more experimental light-scattering curves. Here, we apply the improved data-fitting approach
to three capsid systems—human papillomavirus (HPV), hepatitis B virus (HBV), and cowpea chlorotic mottle virus (CCMV)—to
assess both the range of pathway types the methods can learn and the diversity of assembly strategies in use between these
viruses. The resulting fits suggest three different in vitro assembly mechanisms for the three systems, with HPV capsids fitting
a model of assembly via a nonnucleation-limited pathway of accumulation of individual capsomers while HBV and CCMV
capsids fit similar but subtly different models of nucleation-limited assembly through ensembles of pathways involving trimer-
of-dimer intermediates. The results demonstrate the ability of such data fitting to learn very different pathway types and show
some of the versatility of pathways that may exist across real viruses.INTRODUCTIONSimulation methods have long played an important role
in understanding the biophysics of molecular assembly
systems (1,2), especially where direct experimental obser-
vation is infeasible. Virus capsid assembly has proven
a particularly fertile field for theoretical and computational
models. For example, simulation methods have made it
possible to infer various emergent properties of hypothetical
assembly models (3–6), to explore the effects of perturba-
tions in parameter spaces (5,7–9), and to examine possible
assembly pathways and mechanisms accessible to theoret-
ical models (7,10–13). Simulations have so far had limited
value for predicting the assembly mechanisms of specific
viruses, though, primarily because they depend on physical
parameters that cannot be directly measured by any contem-
porary technology. Those parameters in capsid assembly
models would typically refer to association and dissociation
rates (also called on- and off-rates) among coat proteins.
Several attempts have been made to bridge this gap, such
as using simulation models to find rate ranges plausible for
productive assembly (14,15), using analytical fits of smallSubmitted May 7, 2012, and accepted for publication August 21, 2012.
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(16), applying additional constraints on possible assembly
pathways such as those imposed by virus-specific nucleic
acid interactions (17), inferring approximate averaged rates
from global estimates of the free energy of assembly (16),
inferring approximate rate parameters from structural
models (18,19), or scanning parameter spaces to put
constraints on the range of possible behaviors of a viral
system (5,6,8,9,13,20,21). Precise rate constants are not
known for any real viral system, however, and previous
simulation studies have suggested that the assembly mech-
anisms can be highly sensitive to changes in these and other
parameters (13), casting doubt on the ability of any such
approximations to yield faithful reproductions of real
assembly behavior.
In prior work, we proposed a strategy of using optimiza-
tion algorithms to fit generic coarse-grained simulation
models to specific virus capsid systems (22). Parameter
estimation in a computational or mathematical model is
typically treated as an optimization problem over the param-
eter space to minimize deviation between the model and
some measurable behavior of the real system. In the process,
one infers parameters explaining the data that might be
impossible to compute analytically from any feasible ex-
perimental measure. Our prior work used a previously
developed model for stochastic simulation of viruses
from coarse-grained geometric rule sets, seeking to mini-
mize the deviation between indirect measures of assemblyhttp://dx.doi.org/10.1016/j.bpj.2012.08.057
1546 Xie et al.progress and projections of those measures implied by the
simulations.
To deal with the particular challenges of capsid assembly
systems, the method used a novel, to our knowledge, data-
fitting algorithm that interpolates between response surface
(23) and quasigradient (24) approximations to provide fast
convergence in smooth regions of the objective function
while robustly handling bumpier regions. This method
was specifically applied to light-scattering data, a widely
used technology for monitoring in vitro capsid assembly
systems (25), although the algorithm is not specific to that
data type. We demonstrated the approach on a single curve
of human papillomavirus (HPV) light-scattering data from
Casini et al. (26), showing that the method could learn
a set of physically plausible rate parameters to provide
a good fit to the experimental data. This first study, however,
left several important questions unanswered for evaluating
the future prospects of these methods. Computationally
speaking, it was unclear whether HPV was an unusual
case in having a relatively simple objective surface and,
if so, whether the strategy would generalize to systems
with more complicated objective functions or multiple
near-optimal solutions. Likewise, it was unclear if the model
would have difficulty learning other sorts of assembly
mechanisms than the simple capsomer accretion mechanism
inferred for HPV. Similarly, while theoretical models
suggest even simple structures can be efficiently produced
by diverse sets of possible assembly pathways (13), it was
unclear how much of this potential diversity is found in
actual viruses.
In this article, we seek to address these issues, improving
algorithms for data-fitting to better handle the computational
challenges of learning capsid assembly models and applying
the improved methods to additional icosahedral capsid
systems to assess both the variability in mechanisms
between viruses and the ability of the data-fitting approach
to learn such different mechanisms. To better distinguish
between models of similar quality and thus reduce the poten-
tial for overfitting, we extended our algorithm to allow
simultaneous fitting of curves from multiple assembly
conditions. We also improved the ability of the approach
to take advantage of parallel computing resources by replac-
ing time-consuming large-scale simulations with many par-
allelized small-scale simulations. We have applied our
improved methods to fitting light-scattering curves of hepa-
titis B virus (HBV) and cowpea chlorotic mottle virus
(CCMV), as well as refitting the HPV system. The simula-
tions suggest very different assembly mechanisms between
the three viruses. In the process, they demonstrate the ability
of the methods to learn diverse assembly mechanisms
from these different models. In the process, this study also
provides insight into possible mechanisms and pathways
of capsid assembly and suggests some of the broader utility
that simulation-based data-fitting may have for inferring
otherwise hidden parameters of biophysical systems.Biophysical Journal 103(7) 1545–1554MATERIALS AND METHODS
Simulation model
Our parameter inference strategy relies on fitting coarse-grained simula-
tions of virus capsid assembly to experimental measures of bulk assembly
progress. We simulate the system using a stochastic simulator developed
previously by our group for capsid assembly modeling (13). The basic
building block of our simulations is called a subunit, intended to be the
basic assembly unit of the system. For viral systems, a subunit may be an
individual coat protein or a small stable oligomer of coat proteins. For
HPV, the subunit models a pentameric capsomer of coat proteins, due to
strong experimental evidence that pentamers of coat protein are tightly
associated in HPV and serve as the basic unit of capsid assembly (26,27).
For hepatitis B virus (HBV) and cowpea chlorotic model virus (CCMV),
we use coat dimer subunits because of similar evidence that tightly associ-
ated dimers are the basic assembly units of these systems (28–31).
Interactions between subunits are described by local rules (4,5), coarse-
grained descriptions of the positions, affinities, and kinetics of subunit-
subunit binding sites. A rule set will typically consist of multiple subunit
rules describing the behaviors of distinct conformations of the assembly
subunit(s). Fig. 1 shows rule sets for HPV, HBV, and CCMV described at
the pentamer, dimer, and dimer resolutions, respectively. An HPV capsid
will be described by interaction of 72 subunits following the rules in
Fig. 1 A, an HBV capsid by 120 subunits following the rules of Fig. 1 C,
and a CCMV capsid by 90 subunits following the rules in Fig. 1 E. Nor-
mally, a simulation will be initialized with a set of free subunits in sufficient
numbers to build multiple capsids. Except where otherwise noted, each
simulation trajectory was provided sufficient subunits to assemble 10
(HPV) or 5 (HBV and CCMV) complete capsids.
Simulations are implemented by DESSA, a stochastic simulator of capsid
assembly that samples among possible assembly trajectories in accordance
with the binding rates associated with the rule models (21). DESSA uses
a variant of the stochastic simulation algorithm (32) adapted for more
efficient run time and memory usage on systems with large numbers of
assembly intermediates (33). This stochastic model was chosen because
it allows kinetically correct sampling from the pathway set implied by
a set of local rules in substantially shorter run times and with better scaling
across parameter ranges than was possible with more realistic particle-
based simulations (5–7,9). Details of the DESSA model are described in
Zhang et al. (21). Other simulation parameters are set as in our prior
work (10,13).Measuring quality of fit
The central task in our data fitting is to learn a set of rate parameters such
that a simulated light-scattering dataset provides a close match to a set of
true experimental curves. The output of the DESSA simulator is a time
series providing numbers of oligomers of each size present as a function
of time in the simulation. Following Casini et al. (26), we approximate
the light-scattering curve produced by any given parameter set p over
time t as follows:
Rðt; pÞ ¼
k  c
Pn
i¼ 1
Niðt; pÞ  i2

Pn
i¼ 1
Niðt; pÞ  i
 ¼ k  c Sðt; pÞ:
(1)
Here R(t,p) is the value of a simulated light-scattering curve at time point
t with parameter set p, n is the number of subunits in a full viral capsid,
c is the concentration of subunits, Ni(t,p) is the number of assemblies con-
sisting of i subunits at time t for parameter set p, and k is a scaling factor. To
simplify later formulas, we introduce the notation S(t,p) for the average
Capsid Assembly Pathways 1547assembly size. The parameter set p consists of a set of on- and off-rates for
all possible binding interactions described by the local rule set. R(t,p) is
estimated for each parameter set p by averages over a set of trajectories
to minimize stochastic noise, as described below. In contrast to our prior
work (22), we assume in general that we seek to fit p and possibly k to
a set of true light-scattering curves E1, ., Em representing measurements
of assembly at m distinct concentrations. We measure quality of fit of the
corresponding simulated curves R1(t,p),., Rm(t,p) for a given parameter
set p in terms of a root-mean-square deviation (RMSD),
FðpÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
m
Xm
j¼ 1
 
1
tj
Xtj
t¼ 1

EjðtÞ  k , cj  Sjðt; pÞ
2!vuut :
(2)
where the deviation is computed over a series of discrete time points 0,.,
tj, where tj is the total time measured in curve j.The fitting also requires the scaling factor k, which we handled differ-
ently for the three viruses due to differences in how the data are reported
in their studies. For HPV, the scaling factor is reported as k ¼ 7.04 
108 (26) and that value is used throughout our study. No scaling factor
is reported for the HBV and CCMV studies and we therefore treat these
as additional unknowns to be learned. To infer k, we assume that no
assembly has occurred at the initial time point following addition of
assembly subunits for each true light-scattering curve, allowing us to use
the approximation F(0,p) ¼ k  c. We then seek a best-fit value k to match
that constraint:bk ¼ arg min
k
FðkjpÞ ¼ arg min
k
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2!vuut : (3)Here E* is the modified experimental curve that is shifted along the Y axis
with E*(0) ¼ 0, so E*þk  c starts at k  c. By finding the zero of the
derivative with respect to k, we derive a maximum likelihood estimate of
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We vary the fitting strategy for the three viruses based on differences in how
the data is reported. For HPV, we assume that there is a single known k and
therefore we omit fitting of k. For HBV, we assume there is a single
unknown k that is shared across all curves, and therefore learn this before
multicurve fitting. For CCMV, the strategy differs in two respects:
1. We added a 2.5-s artificial lag phase for each curve to account for uncer-
tainty in the timing of the beginning of assembly in each system, an
important issue for CCMV because of its comparatively more rapid
initiation than the other systems.
2. Due to normalization of the CCMV curves, we must fit each with a sepa-
rate k and average the RMSD across curves:
FðpÞ ¼ 1
m
Xm
j¼ 1
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2vuut : (5)Here, m is again the number of curves to be fit simultaneously, and kj is the
scaling factor for the jth curve derived by applying Eqs. 3 and 4 to a single
curve at a time.Data-fitting algorithm
Data fitting was performed by an improved version of the optimization
algorithm described in Kumar and Schwartz (22). The approach is based
on a search algorithm designed to locally optimize parameter sets by the
quality-of-fit measure F, in turn used as the basis of a heuristic global
search. The global search proceeds by an initial scan of a reduced parameter
space derived by assuming all on-rates in the system are equal and all off-
rates are equal. We then perform a series of local searches, each using the
local optimum of the previous search as an initial guess for a search in an
expanded parameter space produced by allowing two previously equal off-
rates to vary independently. This process repeats until each off-rate is inde-
pendently fit. We use a single on-rate for all binding sites but fit independent
off-rates to balance the need for a model with enough degrees of freedom to
fit the data against the need for a model simple enough to be computation-
ally tractable. In our prior study of HPV alone (22), we instead used inde-
pendent on-rates but chose the alternative here to implicitly model binding
rate as diffusion-limited and thus essentially equal between binding sites.
As we observe below, our believed-to-be-new method infers comparable
HPV free energies and pathways to the prior study.
The order in which independent rates are introduced is determined manu-
ally for each virus. For HPV, after learning a single on- and off-rate for all
binding sites, we then break the off-rates of the four sites into two groups(A j BCD), then three groups (A j BC j D), and finally four (A j B j C j D).
For HBV, the steps by which groups are subdivided are AD j BC, A j D j
BC, and A j D j B j C. The scheme for CCMV is AB j C, and A j B j C.
Local optimization is performed by estimating the quality of fit F at
a series of nearby points on a grid in parameter space and using the points
to infer a gradient vector used to predict a local optimum by steepest
descent while also fitting a quadratic response surface with the nlinfit
function in MATLAB (The MathWorks, Natick, MA) and predicting a local
optimum of that response surface by the fmincon (MATLAB, The Math-
Works) function. The method interpolates between these two approxima-
tions, automatically adjusting a weighting factor to favor the response
surface prediction when the method improved the fit on the previous step
and the steepest-descent prediction when the method failed to improve
the fit on the previous step. This approach relies on a similar intuition to
the standard Levenberg-Marquardt optimization method (34,35) of interpo-
lating between two forms of fit to empirically adjust between algorithms
more suitable to smooth or rough regions of the search space. At each
step, estimates are computed for this grid size by using the previous best
guess, variations of plus or minus one grid step in each individual param-
eter, and variations of plus or minus the grid size in each pair of parameters.
Due to space limitations, we refer the reader to the prior work (22) for
a more detailed description of the fitting algorithm.
While stochastic simulations have algorithmic advantages for simulating
large assembly systems (33), they are problematic for data-fitting because
of the noise they introduce into estimations of fit. There are two ways to
compensate for this disadvantage: run larger individual simulations or run
larger numbers of simulations and average the results. Our prior method
relied primarily on the former strategy, but here we adopt the latter strategyBiophysical Journal 103(7) 1545–1554
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FIGURE 1 Local rule models for capsid assembly systems and corre-
sponding computer models of the complete capsids. (For the capsid models,
solid dots represent subunits and asterisks represent association sites.) (A)
Rule set describing HPV assembly in terms of two pentameric capsomer
subunits with four possible binding interactions. Aþ binding sites bind to
A sites, Bþ to B, Cþ to C, and D0 to other D0 sites. (B) Computer
model of the HPV structure produced by the rules of panel A. (C) Rule
set describing HBV assembly in terms of two coat dimer subunit confor-
mations with four possible binding interactions. Aþ binding sites bind to
A sites, Bþ to B, Cþ to C, and Dþ to D. (D) Computer model of
the HBV structure produced by the rules of panel C. (E) Rule set describing
CCMV assembly in terms of two-coat dimer subunits conformations with
three possible binding interactions. Aþ binding sites bind to A sites,
Bþ to B, and Cþ to C. (F) Computer model of the CCMV structure
produced by the rules of panel E.
1548 Xie et al.to make better use of parallel computing resources to reduce computation
time. We thus use relatively small numbers of subunits per simulation
(720, 600, and 450 for HPV, HBV, and CCMV, respectively) but averageBiophysical Journal 103(7) 1545–1554many trajectories for each estimation of F. The numbers of simulations
required were 120 trajectories per sampled point and 750 to evaluate
a new local minimum. All the replica simulations needed at each step
are automatically submitted and distributed to a compute cluster with
20 Xeon E5520 quad-core processors.Data
Data for the three systems was gathered from prior studies by Casini et al.
(26) (HPV), Zlotnick et al. (16) (HBV), and Zlotnick et al. (30) (CCMV).
In each case, data consist of 90 light-scattering measurements of time
progress of in vitro capsid assembly systems. For HPV, light-scattering
data was gathered from purified L1 coat protein in citrate buffer with
0.5 M NaCl at pH 5.20 for 250 min per experiment (26). For HBV, data
was gathered from stock solutions of Cp149 coat dimers in 0.1 M sodium
bicarbonate and 5 mM DTT at pH 9.5 for 600 s per experiment (16). For
CCMV, experiments were performed on solutions of coat dimers in
200 mM sodium citrate and 1 M NaCl, with data reported for 300 s per
experiment (30). For HPV, we fit to three curves corresponding to capsomer
concentrations of 0.53 mM, 0.72 mM, and 0.80 mM. For HBV, we fit to coat
dimer concentrations of 5.4 mM, 8.2 mM, and 10.8 mM. For CCMV, we fit to
coat dimer concentrations of 14.1, 15.6, and 18.75 mM. In the case of HPV,
we used data provided directly by David Wu (Department of Chemical and
Biological Engineering, Colorado School of Mines) in electronic format,
whereas for HBVand CCMV, we derived data from the appropriate figures
in the references (Fig. 4 C in Zlotnick et al. (16) and Fig. 1 B in Zlotnick
et al. (30), respectively).RESULTS AND DISCUSSION
Our algorithm begins in each case with an initial scan of
a broad range within a simplified parameter space, in which
all on-rates are assumed to be equal as are all off-rates.
These initial scans are used to initialize the broader search,
but are also useful for visualizing the complexity of the
search space. Fig. 2 shows the results of these two-dimen-
sional scans for the three viruses. Fig. 2 A reveals a com-
paratively simple objective function for HPV, consistent
with the results of our prior work (22), with a single strong
local minimum and a relatively smooth approach to that
minimum across the space examined. We note that this
convex appearance does not guarantee that the space is truly
convex, as there may be roughness at a finer scale than we
examine, or that the full parameter space is similarly simple.
Fig. 2 B shows a more complex objective function for HBV,
with two comparably deep local minima and at least one
other less-pronounced minimum. Fig. 2 C shows the com-
parable plot for CCMV, revealing a qualitatively similar
multipeak profile to HBV, although with broader and more
pronounced maxima and minima. Collectively, then, the
three viruses show different portraits consistent with sig-
nificant variability from system-to-system in the nature of
the objective surface and the apparent difficulty of the
associated global optimization problem.
We next proceeded with pseudo-global optimization of
each capsid system starting from the point of lowest
RMSD from each two-parameter scan. For HPV, the search
began at association rate 1400 M1 s1 and dissociation
rate 0.1 s1. Local refinement in the two-parameter space
AB
C
FIGURE 2 Contour plots demonstrating quality of fit in a reduced two-
dimensional parameter space. Each plot shows quality of fit as a function
of one association rate along the x axis and one dissociation rate along
the y axis, with all bonds assumed to exhibit the same pair of rates. Axes
are shown on a logarithmic scale. (Quality of fit is denoted by shading of
the curves, with lighter shades representing high RMSD, i.e., poor fit,
and darker shades representing low RMSD, i.e., good fit.) (A) Quality of
fit of HPV for unified dissociation rates from 0.001 to 10 s1 and unified
association rates from 14 to 1.4  105 M1 s1. (B) Quality of fit of
HBV for unified dissociation rates from 102 to 106 s1 and unified associ-
ation rates from 1.1 103 to 1.1 107 M1 s1. (C) Quality of fit of CCMV
for unified dissociation rates from 102 to 106 s1 and unified association
rates from 3.2  103 to 3.2  107 M1 s1.
TABLE 1 Best-fit rate parameters and corresponding free
energies for the three virus models
Virus Site type
On-rate
(M1 s1) Off-rate (s1)
Free energy
(kCal/mol)
HPV A 1.4  103 0.12 5.6
B 1.4  103 0.11 5.6
C 1.4  103 0.12 5.6
D 1.4  103 0.13 5.5
HBV A 1.4  106 1.2  105 1.5
B 1.4  106 1.4  105 1.4
C 1.4  106 1.4  105 1.4
D 1.4  106 1.2  105 1.5
CCMV A 1.2  106 3.0  104 2.2
B 1.2  106 3.0  104 2.2
C 1.2  106 3.9  104 2.0
Rows correspond to the labeled binding sites of the rule sets of Fig. 1.
Capsid Assembly Pathways 1549adjusted those values to 1400 M1 s1 and 0.11 s1. We
subsequently fixed the forward rate and locally searched
in successively larger spaces of reverse rates, as described
under Data-Fitting Algorithm, above. The algorithm led
to improved fits by adjusting to nearly equal off-rates of0.12 s1 for type A, B, C, and D binding interactions.
Further subdividing the binding site types separates the
four binding interactions to off-rates of 0.12 s1 for type
A, 0.11 s1 for type B, 0.12 s1 for type C, and 0.13 s1
for type D. Over the course of the optimization, the
RMSD improved from an initial value of 5.165  105
for the best-fit grid point to 4.914  105 after two-param-
eter local optimization and to 4.772  105, 4.772  105,
and 4.736  105 after successive expansions of the param-
eter space followed by local optimization. Moving from two
to three parameters thus provided a comparable improve-
ment to that achieved by the initial local optimization, but
subsequent increases in parameter space provided little
additional improvement.
Table 1 shows the final fit parameters for HPV. Although
we altered the basic model assumptions in this work relative
to our prior work (22) by assuming a shared on- rather than
off-rate, the search ended with comparable parameter esti-
mates. As in that prior work, we found similar free energies
between binding sites, with each now inferred to have a free
energy of 5.5 to 5.6 kcal/mol. These energies are some-
what stronger than prior estimates of mean free energies of
coat-coat binding in other systems, which have covered
a range of ~2.8 kcal/mol for HBV (14) to 4.4 kcal/mol
for phage P22 (15). Nonetheless, estimates would appear
to be physically plausible. The fit shows essentially equal
affinity for all binding sites with the exception of a slightly
stronger interaction for Aþ/A binding, which binds pen-
tameric capsomers to hexameric capsomers. Fig. 3 A shows
the quality of fit of the best-fit model to the true light scat-
tering from Casini et al. (26), revealing a generally good
fit to both short- and long-timescale features of the curves,
although with a somewhat underestimated curve at 0.72 mM
and a somewhat overestimated curve at 0.80 mM. In
addition, the true data tends to show a sharper initial slope
at the end of the lag phase than do the simulated curves,
although that may in part reflect deviation between the
idealized light-scattering model we assume and the true
sensitivity of the instrument for smaller oligomers.Biophysical Journal 103(7) 1545–1554
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FIGURE 3 Best fits of experimental and model light-scattering curves
for the three capsid systems. Each figure shows three experimental curves
measured at different concentrations (solid gray lines) and the correspond-
ing best-fit model curves (black dashed lines). (A) HPV. (B) HBV. (C)
CCMV.
A
B
C
FIGURE 4 Mass fractions of intermediates versus time for sample trajec-
tories of the three capsid systems. Each curve corresponds to a single size of
intermediate species. (Insets in each plot) Magnification of early stages of
the reaction. While all possible intermediate sizes are plotted, for simplicity
a key is provided only for sizes 2–8. (A) Mass fractions versus time for
720 HPV capsomer subunits at 0.80 mM. (B) Mass fractions versus time
for 600 HPV dimer subunits at 10.8 mM. (C) Mass fractions versus time
for 450 CCMV dimer subunits at 14.1 mM.
1550 Xie et al.A key point of these studies is to infer features of capsid
assembly pathways. For this purpose, we examined interme-
diate distributions as functions of time. Fig. 4 A plots the
results from a sample trajectory for HPV at 0.80 mM. The
curves show no preference for building up any specific pools
of small oligomers. Neither do they show a pronounced
depletion for larger oligomers, as we would expect for
a nucleation-limited assembly. Rather, the plots show the
mass fraction of each intermediate coming up slightly later
and slightly lower than the next smaller intermediate. This
pattern is consistent with a model of assembly by successive
accretion of individual capsomers without a defined nucle-
ation step. Fig. 5, A–C, visualizes the pathway space by
plotting how frequently any given reactant oligomer sizes
are used to assemble any given product oligomer size. The
plot confirms that each oligomer size is normally produced
by addition of a single capsomer to the next smaller olig-
omer size, with the exception of some rare reactions
between pairs of oligomers during the earlier steps of
assembly. This conclusion is consistent with that found by
our prior method fitting to a single light-scattering curve
(22).Comparison between concentrations shows that theBiophysical Journal 103(7) 1545–1554same nonnucleation-limited capsomer addition pathway is
used across the concentration range with only variation in
the frequency of relatively rare oligomer-oligomer binding
steps early in assembly. At higher concentrations, such olig-
omer-oligomer binding is more often observed, although
still rare.
ForHBV,we began the search at on-rate 1.1 106M1 s1
and off-rate 1.0  105 s1, with the local search yielding an
improved fit at 1.4  106 M1 s1 and 1.3  105 s1.
RMSD improved from 0.3304 to 0.2784, 0.2768, 0.2768,
and 0.2654 over successive steps of local optimization
The final fit yielded on-rate 1.4  106 M1 s1 for all
bonds and off-rates of 1.2  105 s1 for types A and D and
1.4  105 s1 for sites B and C.
Table 1 shows the final parameter fits for HBV. Free ener-
gies of binding are substantially weaker than those found
for HPV, in the range of 1.4 to 1.5 kcal/mol. Because
there is an average of two binding interactions per dimer
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FIGURE 5 Visualization of reaction usage for viral assembly reactions. Each plot is organized into a set of rows and columns such that the shading of the
box in row i and column j denotes the fraction of oligomers of size i produced by a binding reaction involving an oligomer of size j. (Lighter colors) Higher
frequencies; (darker colors) lower frequencies (with black representing a reaction unobserved in the course of the simulations). Each subfigure shows the full
plot of all possible assembly sizes. (Inset in the upper right) Magnification of a portion of the upper-left region of the full plot corresponding to reactions
producing smaller oligomers. (A) HPVat 0.53 mM. (B) HPVat 0.72 mM. (C) HPVat 0.80 mM. (D) HBVat 5.4 mM. (E) HBVat 8.2 mM. (F) HBVat 10.8 mM.
(G) CCMV at 14.1 mM. (H) CCMV at 15.6 mM. (I) CCMV at 18.75 mM.
Capsid Assembly Pathways 1551in a complete capsid, the average free energy per dimer in
a complete capsid would be ~2.9 kcal/mol, well in line
with earlier estimates by Ceres and Zlotnick (14). The in-
ferred model is thus also consistent with the argument of
Zlotnick et al. for the necessity of weak interactions to allow
efficient assembly.We note that the absolute rates inferred in
this model are much higher than those inferred for HPV, sug-
gesting that HBVassembly proceeds with far more trial-and-
error, repeatedly attaching and detaching isolated proteins
until stable substructures form and can act as ratchets forcing
the assembly process forward. Fig. 3B shows the correspond-
ing curve fits of the best-fit parameters to the real light-scat-
tering data. As with HPV, the model shows a generally good
fit to both early and late phases of assembly, although with
some underestimation of the 5.4- and 10.8-mM curves and
overestimation of the 8.2-mM curve.
Profiles of intermediates and reaction usage present
a very different picture for HBV than was seen for HPV.Fig. 4 B shows a sample simulation trajectory for the best-
fit parameters at 10.8 mM. The most prominent feature of
the plot is a set of intermittent spikes in which the system
rapidly cycles through a series of successively larger inter-
mediates, culminating in production of a new capsid. These
spikes are the signature of nucleation-limited growth, with
each spike touched off by production of some small nucleus
followed by rapid completion of the capsid through a series
of elongation reactions. Another prominent feature of the
plot is the existence of a pool of free trimers (hexamers of
coat protein) forming quickly and persisting during the
assembly reaction. Monomers and trimers of subunits
(dimers and hexamers of coat proteins) apparently reach
an equilibrium with one another early in the reaction that re-
adjusts with the production of each capsid.
The reaction usage profile in Fig. 5 B reveals that mono-
mers and trimers are used at random for individual steps of
the assembly, with monomers usually favored but trimersBiophysical Journal 103(7) 1545–1554
1552 Xie et al.used roughly 10–20% of the time at most elongation steps.
The system thus appears to be described not by a single
pathway but by an ensemble of many distinct assembly
pathways. The production of small oligomers revealed in
the inset shows a more complex profile, with more frequent
use of trimers and occasionally pentamers, and with produc-
tion of octamers in particular occurring primarily by binding
trimers to pentamers. While it is difficult to define a precise
set of steps as the nucleation from this profile, the results do
suggest that a low-frequency pentameric form plays an
important role in initiating assembly. The profiles are nearly
identical across the twofold concentration change shown in
Fig. 5, D–F.
For CCMV, optimization was performed starting from
on-rate 1.0  106 M1 s1 and off-rate 3.2  104 s1.
The initial local search led to a slight adjustment of the
initial on-rate to 1.2  106 M1 s1 and off-rate to 3.5 
104 s1, whereas subsequent refinement allowed fitting to
two distinct off-rates for the three binding interaction types:
3.0  104 s1 for types A and B and 3.9  104 s1 for type
C. RMSD improved from 0.8846 after the grid search to
0.8529, 0.8142, and 0.8142 after local optimization in
two-, three-, and four-dimensional spaces. The similarity
in off-rates of type A and B is consistent with the similarity
in structure and geometry of the two binding types. The final
fits, provided in Table 1, showed a free energy range from
2.0 kcal/mol to 2.2 kcal/mol, intermediate between the
strong interactions inferred for HPVand the weaker interac-
tions inferred for HBV. The free energies and the kinetic
rates are closer to those of HBV and the model would thus
seem to suggest that assembly of CCMV, like that of
HBV, involves a considerable amount of trial-and-error
before forming stable substructures by which the overall
assembly can proceed.
The overall assembly process of the CCMV model also
appears qualitatively more similar to that of HBV than
HPV. Mass fractions of CCMV intermediates versus time,
shown in Fig. 4 C for 14.1 mM, again show the spikes char-
acteristic of a nucleation-limited growth mechanism. Like
with HBV, there are also persistent pools of oligomers
throughout the assembly, with trimers appearing to domi-
nate as with HBV. Unlike with HBV, a small standing
population of pentamers becomes apparent late in the reac-
tion. Both viruses show a qualitatively similar process of
gradual accumulation of trimers in the lag between nucle-
ations, which are then rapidly depleted during elongation
of a new capsid. Reaction frequencies visualized in Fig. 5,
G–I, shows that assembly most often proceeds by monomer
additions, but that trimer additions occur with lower
frequencies, providing an ensemble of secondary assembly
pathways. Early steps in assembly show a similar frequency
profile to that observed for HBV, although there also appears
to be a single frequently used step involving large (10-mer
and 17-mer) oligomers that is not seen with HBV. Like
HBV, CCMV is inferred to assemble through an ensembleBiophysical Journal 103(7) 1545–1554of distinct pathways rather than a single defined pathway.
Pathway usage appears insensitive to at least the range of
concentration changes examined in Fig. 5, G–I.CONCLUSION
In this work, we have advanced methods for simulation-
based data fitting for learning physical parameters of self-
assembly systems and applied these methods to a study of
kinetic rate parameters of three icosahedral virus capsid
assembly systems. The results of this work allow us to
draw two conclusions about the methodology and the capsid
systems themselves:
1. The results demonstrate that the algorithms are, at least
in principle, able to learn different kinds of assembly
pathways and rate parameters for a small collection
of icosahedral viruses with qualitatively similar
structures and bulk assembly kinetics. Our parameter
estimation technique generates good fits between ex-
perimental and simulated light-scattering curves, even
when fitting a common parameter set to multiple curves
at different concentrations to reduce redundancy of
solutions.
2. The results are suggestive of some of the variability
in assembly mechanisms that may exist between struc-
turally similar viruses. The inferred models show
a variety of behaviors, including either nucleation-
limited or nonnucleation-limited assembly, monomer-
based or hierarchical oligomer-based assembly, and
assembly consistent with a single well-defined pathway
or assembly that can only be described as an ensemble
of a very large collection of distinct pathways.
Two of the viruses, HBV and CCMV, fit pathways with
many similar features despite different shell geometries
shells and despite sizeable differences in inferred rate
parameters. The third virus, HPV, shows very different
behavior in both rates and pathways. These three examples,
then, collectively demonstrate that there may not be
any consistent paradigm of virus assembly but rather a
diversity of strategies for assembly comparable to the great
diversity seen in viral structures and other features of their
life cycles.
The inferred models raise several questions about
assembly of the specific viruses examined. One surprising
result is the apparent lack of nucleation-limited assembly
in the HPV model, a feature noted in our earlier work
on that system (22). Numerous theoretical models have
suggested nucleation-limited growth as a key feature for
preventing kinetic traps in assembly (5,7–9,20) and indeed
we see large amounts of incomplete species in the HPV
simulations. This lack of nucleation-limited growth may
reflect some inability of the model to learn the correct
assembly pattern, perhaps because it lacks some important
feature essential to true HPV assembly. The prior work left
Capsid Assembly Pathways 1553open the possibility that the model-fitting technique might
have some inherent inability to discover nucleation-limited
parameter sets, although the currently available results
from HBV and CCMV now refute that hypothesis.
Another intriguing observation is the apparent lack of
a single defined pathway for HBV and CCMV in favor of
what is, effectively, a random sampling from a large
ensemble of possible pathways involving either incorpora-
tion of monomers or oligomers at each step of assembly.
While there is no clear reason as to why virus assembly
should not proceed by stochastic sampling from a large
set of possible pathways, the assumption that a reaction
has a defined pathway is nonetheless often implicit in how
we reason about biochemical systems. A failure of this
assumption may have important implications for our use
of simplified theoretical models to describe and reason
about such systems, especially on small scales at which
the stochastic nature of the pathway space should be partic-
ularly pronounced.
Furthermore, an absence of any individual reactions
necessary to productive assembly may have important
practical implications for efforts to develop capsid assembly
targeted antivirals (36–38). A final observation is that the
similar pathway usage across concentrations suggests that
all three viruses sit at points in parameter space that are
relatively insensitive to perturbation, in contrast to expecta-
tions from theoretical studies (13) that pathway usage is
quite sensitive to small changes in model parameters across
a large fraction of the parameter space. We can speculate
that such robustness to perturbation might be a general
feature evolutionarily selected in real capsid assembly,
although far more examples would be needed to draw any
such conclusion with confidence.
An obvious question with any such study is whether the
parameters or pathways learned are in fact correct for
the systems studied. While the results show good fits to
the data and a reasonable ability to generalize to different
concentrations for any single virus, they also show some
imperfections, e.g., in the initial slope of the HPV curves
at the end of the lag phase. Because we have no direct way
to measure the true rates or to directly observe assembly
pathways, we cannot be sure if these deviations reflect
minor inaccuracies in the models or if they suggest the
models are fundamentally wrong. It is also possible that
there are spaces of distinct solutions equally consistent
with the available data, in which case the method might
arbitrarily fit to the wrong one.
Furthermore, this is a difficult optimization problem due
to the high cost of simulations and the lack of any analyt-
ical guarantees of convexity of the search space, preventing
an exhaustive global search of potential parameter sets. We
therefore cannot guarantee that the solutions found are
globally optimal, only that they provide reasonably good
fits to the observed data. Even assuming the inferred
models are correct, they are nonetheless correct modelsof in vitro assembly systems and not of the viruses in vivo.
It remains an open question whether the in vitro pathways
are faithful reproductions of those used in vivo. There are
many ways in which one might expect the environment
of capsid assembly in vivo to differ from that of the
in vitro assembly systems examined here, from generic
features like nonspecific macromolecular crowding (39)
to system-specific effects like the varying roles of scaf-
folding proteins and viral nucleic acid in capsid assembly
(40), or the importance of chaperone proteins in HPV
assembly (41).
There are many avenues by which this work might be
further advanced. Our best-fit models allow us to make
a variety of predictions about assembly intermediates and
key steps in assembly that might, in principle, be experi-
mentally tested in future studies. One might similarly ask
how these models can assist us in designing strategies to
selectively alter assembly pathways, for example by identi-
fying vulnerable steps in assembly that could be targeted
by antivirals (36–38), or projecting how hypothetical muta-
tions in coat proteins might alter assembly pathways. The
computational models learned here also provide a platform
from which one could test whether variations that are likely
to separate in vitro from in vivo models would be expected
to alter assembly pathways.
It would also be useful to examine a larger space of
possible models to see how much greater diversity is found
across the universe of real viruses and whether the common
features of the systems observed here, such as their apparent
robustness to parameter changes, are general features of real
assembly systems. Such studies are infeasible at the time of
this writing because there are few viruses for which in vitro
models and light-scattering data are available, although the
methods developed here, in principle, might be applied to
other indirect measures of assembly progress. There is
also considerable room for algorithmic improvements to
accelerate the computationally costly searches, provide
stronger guarantees of solution optimality, or find other
bases by which one might distinguish solutions of similar
quality of fit.
Finally, we note that virus capsids, due to their high
symmetry and very large number of possible pathways,
would be expected to be a particularly challenging system
for such simulation-based data fitting. The ability of such
methods to find good models for viral systems may there-
fore be taken as an indication that similar methods are likely
to have much broader value in inferring experimentally
inaccessible features of assembly systems or of biophysical
systems in general.We thank David Wu and Adam Zlotnick for providing raw experimental
data and Roman Tuma for helpful discussions.
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